Goldcoast Resource Corp. (GCR.CX)
0.45
-0.15
(-25.00%)
CAD |
CNSX |
Oct 13, 16:00
Goldcoast Resource Net Income (Quarterly) : -0.0999M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0999M |
| March 31, 2026 | -0.1629M |
| December 31, 2025 | -0.0639M |
| September 30, 2025 | -0.0702M |
| June 30, 2025 | -11.63M |
| March 31, 2025 | -1.28M |
| December 31, 2024 | -3.012M |
| September 30, 2024 | 2.939M |
| June 30, 2024 | 1.323M |
| March 31, 2024 | -67.08M |
| December 31, 2023 | 0.36M |
| September 30, 2023 | -0.4888M |
| June 30, 2023 | -2.235M |
| March 31, 2023 | -2.767M |
| December 31, 2022 | -1.128M |
| September 30, 2022 | -1.008M |
| June 30, 2022 | -1.180M |
| March 31, 2022 | -1.068M |
| December 31, 2021 | -1.229M |
| September 30, 2021 | -1.096M |
| June 30, 2021 | -1.207M |
| December 31, 2020 | -0.073M |
| September 30, 2020 | -0.0076M |
| June 30, 2020 | -0.0075M |
| March 31, 2020 | -0.0044M |
| Date | Value |
|---|---|
| December 31, 2019 | -0.0066M |
| September 30, 2019 | -0.0031M |
| June 30, 2019 | -0.0048M |
| March 31, 2019 | -0.0046M |
| December 31, 2018 | -0.0317M |
| September 30, 2018 | -0.0046M |
| June 30, 2018 | -0.0046M |
| March 31, 2018 | 0.0276M |
| December 31, 2017 | -0.004M |
| September 30, 2017 | -0.0044M |
| June 30, 2017 | -0.0058M |
| March 31, 2017 | -0.0057M |
| December 31, 2016 | -0.0317M |
| September 30, 2016 | -0.0075M |
| June 30, 2016 | -0.0104M |
| March 31, 2016 | -0.0052M |
| December 31, 2015 | 0.0101M |
| September 30, 2015 | -0.0083M |
| June 30, 2015 | -0.0098M |
| March 31, 2015 | -0.0067M |
| December 31, 2014 | -0.0113M |
| September 30, 2014 | -0.011M |
| June 30, 2014 | -0.0229M |
| March 31, 2014 | -0.0149M |
| December 31, 2013 | -0.0302M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Kane Biotech, Inc. | -0.8336M |
| Quest PharmaTech, Inc. | 3.401M |
| BriaCell Therapeutics Corp. | -9.920M |
| Vaxil Bio Ltd. | -0.064M |
| Waverley Pharma, Inc. | -0.1437M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0999M |
| EPS Diluted (Quarterly) | -0.0431 |
| Enterprise Value | 0.6993M |
| Earnings Yield | -39.36% |
| Normalized Earnings Yield | -38.49 |